Join
Live feed
·
INSIDERFilingvia Quantisnow
Ayala Pharmaceuticals Inc. logo

SEC Form 4: Maimon Yossi was granted 50,000 shares, increasing direct ownership by 252% to 69,872 units

ByQuantisnow·Wall Street's wire, on your screen.
AYLA· Ayala Pharmaceuticals Inc.
Consumer Discretionary
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AYLA (Ayala Pharmaceuticals Inc.) and more on Quantisnow.

SEC Form 4: Maimon Yossi was granted 50,000 shares, increasing direct ownership by 252% to 69,872 units | Quantisnow